Why the study?
Purified low-fat diets commonly used in control animals contain components linked to metabolic and vascular dysfunction, raising concern that they could promote adverse vascular and metabolic outcomes.
Does a purified low-fat diet compared to standard chow impair glucose homeostasis and vascular function in C57BL/6J mice?
Does a purified low-fat diet compared to standard chow impair glucose homeostasis and vascular function in C57BL/6J mice?
The choice of control diet (purified low-fat vs. standard chow) in metabolic studies significantly impacts baseline glucose homeostasis and vascular function, which may confound experimental results.
Answers are grounded in this paper and cite their sources.
Control diet variability may confound animal cardiometabolic findings; leaves open standardization needs for translational research.
The experimental approach for the study of cardiometabolic disorders requires the use of animal models fed with commercial diets whose composition differs notably, even between diets used for control groups. While chow diets are usually made of agricultural by-products, purified low-fat diets (LF) contain a higher percentage of easy metabolizable carbohydrates, together with a reduced amount of polyunsaturated fatty acids, micronutrients and fiber, all associated with metabolic and vascular dysfunction. We hypothesize that the LF diet, commonly used in control animals, could promote adverse vascular and metabolic outcomes. To address this issue, 5-week-old male C57BL6J mice were fed with a standard (Chow) or a LF diet for 6 weeks. Changes in body weight, adiposity, biochemical parameters, systemic and aortic insulin sensitivity and endothelial function were recorded. LF diet did not modify body weight but significantly impaired systemic glucose tolerance and increased triglycerides and cholesterol levels. Endothelial function and aortic insulin sensitivity were significantly impaired in the LF group, due to a reduction of NO availability. These findings highlight the importance of selecting the proper control diet in metabolic studies. It may also suggest that some cardiometabolic alterations obtained in experimental studies using LF as a control diet may be underestimated.
No takes yet. Share an insight, caveat, or question.
González‐Blázquez et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: